Interpreting beta-blocker therapy after myocardial infarction: Methodological considerations on trial selection and effect measures
Medicina Intensiva (English Edition)
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
Interpreting beta-blocker therapy after myocardial infarction: Methodological considerations on trial selection and effect measures. // Medicina Intensiva (English Edition). – URL: https://www.sciencedirect.com/science/article/pii/S2173572726002651?dgcid=rss_sd_all
Interpreting beta-blocker therapy after myocardial infarction: Methodological considerations on trial selection and effect measures. Medicina Intensiva (English Edition). https://www.sciencedirect.com/science/article/pii/S2173572726002651?dgcid=rss_sd_all
“Interpreting beta-blocker therapy after myocardial infarction: Methodological considerations on trial selection and effect measures.” Medicina Intensiva (English Edition).
@article{article58303,
title = {Interpreting beta-blocker therapy after myocardial infarction: Methodological considerations on trial selection and effect measures},
journal = {Medicina Intensiva (English Edition)},
url = {https://www.sciencedirect.com/science/article/pii/S2173572726002651?dgcid=rss_sd_all}
}